Vitamin D: Balancing cutaneous and systemic considerations

Southern Medical Journal

Volumn 94, Issue 1, 2001, Pages 58-64

  Fuller, Kathleen E ^a   Casparian, J Michael ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ADULT; AGE; AGED; CHILD; DIET; DIET SUPPLEMENTATION; FOOD ANALYSIS; HUMAN; METABOLISM; MIDDLE AGED; NUTRITIONAL REQUIREMENT; OSTEOPOROSIS; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY;

ADULT; AGE FACTORS; AGED; CHILD; DIET; DIETARY SUPPLEMENTS; FOOD ANALYSIS; HUMANS; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; OSTEOPOROSIS; PUBLIC HEALTH PRACTICE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0035233914     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200101000-00011     Document Type: Article

References (33)

1. Gilchrest BA, Eller MS, Geller AC, et al: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340:1341-1348
2. Marks R: Prevention and control of melanoma: the public health approach. CA Cancer J Clin 1996; 46:199-216
3. Rigel DS: Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment. CA Cancer J Clin 1996; 46:193-198
4. Lim HW, Cooper K: The health impact of solar radiation and prevention strategies: report of the Environment Council, American Academy of Dermatology. J Am Acad Dermatol 1999; 41:81-99
5. Holick MF: Vitamin D and bone health. J Nutr 1996; 126:1159S-1164S
6. Farrerons J, Barnadas M, Rodriguez J, et al: Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. Br J Dermatol 1998; 139:422427
7. Marks R, Foley PA, Jolley D, et al: The effect of regular sun-screen use on vitamin D levels in an Australian population. Arch Dermatol 1995; 131:415-421
8. Sollitto RB, Kraemer KH, DiGiovanna JJ: Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J Am Acad Dermatol 1997; 37:942-947
9. Vieth R: Vitamin D supplementation 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69:842-856
10. Malabanan A, Veronikis IE, Holick MF: Redefining vitamin D insufficiency. Lancet 1998; 351:805-806
11. Freaney R, McKenna MJ: Groups at risk need supplementation, and milk could be fortified. BMJ 1999; 318:1284
12. Dawson-Hughes B, Harris SS, Krall EA, et al: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337:670-676
13. Rostrand SG: Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30:150-156
14. Krause R, Buhring M, Hopfenmuller W, et al: Ultraviolet B and blood pressure. Lancet 1998; 352:709-710
15. Scragg R: Sunlight, vitamin D, and cardiovascular disease. Calcium-Regulating Hormones and Cardiovascular Function. Crass MF II, Avioli LV (eds). Boca Raton, Fla, CRC Press, 1995, pp 213-237
16. Studzinski GP, Moore DC: Sunlight, can it prevent as well as cause cancer? Cancer Res 1995; 55:4014-4022
17. Blutt SE, Weigel NL: Vitamin D and prostate cancer. Proc Soc Exp Biol Med 1999; 221:89-98
18. Vandewalle B, Hornez L, Wattez N, et al: Vitamin D, derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis. Int J Cancer 1995; 61:806-811
19. Hofer H, Ho G-M, Peterlik M, et al: Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. J Pharmacol Exp Ther 1999; 291:450-455
20. 3 is mediated by mutual modulation of receptor expression. Eur J Cancer 1998; 34:2119-2125
21. Ekman P: Genetic and environmental factors in prostate cancer genesis, identifying high-risk cohorts. Eur Urol 1999; 35:362-369
22. Peehl DM: Vitamin D and prostate cancer risk. Eur Urol 1999; 35:392-394
23. Hanchette CL, Schwartz GG: Geographic patterns of prostate cancer mortality. Cancer 1992; 70:2861-2869
24. 3, and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res 1999; 5:695-703
25. Chen TC: Photobiology of vitamin D. Vitamin D: Physiology, Molecular Biology, and Clinical Applications. Holick MF (ed). Totowa, NJ, Humana Press Inc, 1999, pp 17-37
26. DeLuca HF: Vitamin D and its metabolites. Modern Nutrition in Health and Disease. Shils ME, Young VR (eds). Philadelphia, Lea & Febiger, 7th Ed, 1998, pp 313-327
27. Henry HL, Norman AW: Metabolism of vitamin D. Disorders of Bone and Mineral Metabolism. Coe FL, Favus MJ(eds). New York, Raven Press Ltd, 1991, pp 149-162
28. Delvin EE, Salle BL, Glorieux FH: Vitamin D and calcium homeostasis in pregnancy: feto-maternal relationships. Rickets. Glorieux FH (ed). New York, Raven Press Ltd, 1991, pp 91-105
29. Mankin HJ: Rickets, osteomalacia, and renal osteodystrophy: an update. Orthop Clin North Am 1990; 21:81-96
30. Boyle IT: Bones for the future. Acta Paediatr Scand Suppl 1991; 373:58-65
31. Hess AF: Rickets, Including Osteomalacia and Tetany. Philadelphia, Lea & Febiger, 1929
32. McCollum EV, Simmonds N, Becker JE, et al: Studies on experimental rickets. XXI. an experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922; 53:293-312
33. Yates AA, Schlicker SA, Suitor CW: Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998; 98:699-706